Hapten Sciences, Inc. — Form D/A

Hapten Sciences, Inc. of MEMPHIS, TN, a company, filed a Form D amendment with the SEC on 2018-09-20. The offering totals $2.2M, of which $1.6M was reported sold. Industry: Pharmaceuticals.

Offering

Filed: 2018-09-20
Form: D/A
Accession: 0001526465-18-000003
Industry: Pharmaceuticals
Exemptions: 06b
Total offering: $2.2M
Amount sold: $1.6M
Remaining: $612K
Investors: 5
Date of first sale: 2018-01-30
Security types: debt
Revenue range: Decline to Disclose
SEC file number: 021-306227

Issuer

Name: Hapten Sciences, Inc.
CIK: 0001526465
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2011
Address: 40 S. MAIN, SUITE 2300, MEMPHIS, TN, 38103
Phone: 9017473946

Officers, directors & promoters (12)

Name	Role	Location
Stephen L Bandak	Director	Memphis, TN
Gary L Stevenson	Director	Memphis, TN
Gary Prosterman	Director	Memphis, TN
Gary Prosterman	Executive Officer	Memphis, TN
Gary Prosterman	Promoter	Memphis, TN
Joseph L Zakrzewski	Director	Memphis, TN
Gary I Stevenson	Director	Memphis, TN
Joseph I Zakrzewski	Director	Memphis, TN
Stephen I Bandak	Director	Memphis, TN
Raymond J Hage	Director	Memphis, TN
Raymond J Hage	Executive Officer	Memphis, TN
Raymond J Hage	Promoter	Memphis, TN

Other filings by this issuer (13)

Filed	Form	Offering	Sold
2021-08-10	D	$3.0M	—
2019-10-31	D	$1.5M	$886K
2018-02-26	D/A	$2.0M	$633K
2018-02-22	D	$2.0M	$108K
2017-02-14	D	$1.2M	$1.2M
2016-01-12	D/A	$1.7M	$1.2M
2015-09-09	D	$225K	$225K
2015-04-16	D	$250K	$250K
2015-02-05	D	$100K	—
2015-02-05	D/A	$1.2M	$625K
2014-01-02	D/A	$1.2M	$475K
2013-02-20	D	$500K	—
2011-07-21	D	$1.6M	—

More